FdaApplication
ANDA 206912
Identifiers
- fda_app_no: ANDA206912
Properties
| Property | Value |
|---|---|
| applicant_name | HETERO LABS LTD UNIT III |
| application_type | ANDA |
| approval_date | 2019-10-08 |
Products (8)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PREGABALIN | PREGABALIN | 100MG | CAPSULE;ORAL |
| PREGABALIN | PREGABALIN | 50MG | CAPSULE;ORAL |
| PREGABALIN | PREGABALIN | 75MG | CAPSULE;ORAL |
| PREGABALIN | PREGABALIN | 225MG | CAPSULE;ORAL |
| PREGABALIN | PREGABALIN | 200MG | CAPSULE;ORAL |
| PREGABALIN | PREGABALIN | 300MG | CAPSULE;ORAL |
| PREGABALIN | PREGABALIN | 25MG | CAPSULE;ORAL |
| PREGABALIN | PREGABALIN | 150MG | CAPSULE;ORAL |
8 products